BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Worni M, Shah KN, Clary BM. Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment. Curr Oncol Rep. 2014;16:407. [PMID: 25129331 DOI: 10.1007/s11912-014-0407-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Sun X, Li K, Wang H, Xia Y, Meng P, Leng X, Abdulhay E. MiR-483 Promotes Colorectal Cancer Cell Biological Progression by Directly Targeting NDRG2 through Regulation of the PI3K/AKT Signaling Pathway and Epithelial-to-Mesenchymal Transition. Journal of Healthcare Engineering 2022;2022:1-9. [DOI: 10.1155/2022/4574027] [Reference Citation Analysis]
2 Kim AY, Miller A. Evaluation of Surefire’s precision direct-to-tumor embolization device to augment therapeutic response to intra-arterial, liver-directed therapies for patients with primary and secondary liver cancers. Expert Review of Medical Devices 2016;13:435-43. [DOI: 10.1586/17434440.2016.1164594] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
3 Gu X, Jiang Y, Xue W, Song C, Wang Y, Liu Y, Cui B. SPNS2 promotes the malignancy of colorectal cancer cells via regulating Akt and ERK pathway. Clin Exp Pharmacol Physiol 2019;46:861-71. [PMID: 31206801 DOI: 10.1111/1440-1681.13124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
4 Holzner PA, Makowiec F, Klock A, Glatz T, Fichtner-Feigl S, Lang SA, Neeff HP. Outcome after hepatic resection for isolated non-colorectal, non-neuroendocrine liver metastases in 100 patients - the role of the embryologic origin of the primary tumor. BMC Surg 2018;18:89. [PMID: 30373582 DOI: 10.1186/s12893-018-0424-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chapman WC, Korenblat KM, Fowler KJ, Saad N, Khan AS, Subramanian V, Doyle MBM, Dageforde LA, Tan B, Grierson P, Lin Y, Xu M, Brunt EM. Hepatocellular carcinoma: Where are we in 2018? Curr Probl Surg 2018;55:450-503. [PMID: 30526875 DOI: 10.1067/j.cpsurg.2018.10.002] [Reference Citation Analysis]
6 Qadan M, D'Angelica MI. Complex Surgical Strategies to Improve Resectability in Borderline-Resectable Disease. Curr Colorectal Cancer Rep. 2015;11:369-377. [PMID: 28090195 DOI: 10.1007/s11888-015-0290-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Vondran FWR, Oldhafer F, Ringe KI, Wirth TC, Kleine M, Jäger MD, Klempnauer J, Bektas H. Associating Liver Partition and Portal vein ligation for Staged hepatectomy after pre-operative chemotherapy. ANZ J Surg 2018;88:E324-8. [PMID: 28419692 DOI: 10.1111/ans.13944] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
8 Sparrelid E, Jonas E, Tzortzakakis A, Dahlén U, Murquist G, Brismar T, Axelsson R, Isaksson B. Dynamic Evaluation of Liver Volume and Function in Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy. J Gastrointest Surg 2017;21:967-74. [PMID: 28283924 DOI: 10.1007/s11605-017-3389-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
9 Kitano Y, Hayashi H, Matsumoto T, Kinoshita S, Sato H, Shiraishi Y, Nakao Y, Kaida T, Imai K, Yamashita YI, Baba H. Borderline resectable for colorectal liver metastases: Present status and future perspective. World J Gastrointest Surg 2021; 13(8): 756-763 [PMID: 34512899 DOI: 10.4240/wjgs.v13.i8.756] [Reference Citation Analysis]
10 Li J, Ewald F, Gulati A, Nashan B. Associating liver partition and portal vein ligation for staged hepatectomy: From technical evolution to oncological benefit. World J Gastrointest Surg 2016; 8(2): 124-133 [PMID: 26981186 DOI: 10.4240/wjgs.v8.i2.124] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
11 Xin H, Wang C, Liu Z. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα. BMC Cancer 2019;19:30. [PMID: 30621631 DOI: 10.1186/s12885-018-5245-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
12 Rey Chaves CE, Conde D, Tapias L, Roa I, Sabogal Olarte JC. Associating liver partition and portal vein ligation (ALPPS): A two staged procedure, in Bogotá Colombia. Case report and literature review. Int J Surg Case Rep 2021;89:106560. [PMID: 34808445 DOI: 10.1016/j.ijscr.2021.106560] [Reference Citation Analysis]
13 Zou SL, Chen YL, Ge ZZ, Qu YY, Cao Y, Kang ZX. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer. Cancer Biomark 2019;26:69-77. [PMID: 31306108 DOI: 10.3233/CBM-190156] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
14 Khan AS, Dageforde LA. Cholangiocarcinoma. Surg Clin North Am. 2019;99:315-335. [PMID: 30846037 DOI: 10.1016/j.suc.2018.12.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 14.0] [Reference Citation Analysis]
15 Jin W, Shi J, Liu M. Overexpression of miR-671-5p indicates a poor prognosis in colon cancer and accelerates proliferation, migration, and invasion of colon cancer cells. Onco Targets Ther 2019;12:6865-73. [PMID: 31686843 DOI: 10.2147/OTT.S219421] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
16 Giannios P, Toutouzas KG, Matiatou M, Stasinos K, Konstadoulakis MM, Zografos GC, Moutzouris K. Visible to near-infrared refractive properties of freshly-excised human-liver tissues: marking hepatic malignancies. Sci Rep 2016;6:27910. [PMID: 27297034 DOI: 10.1038/srep27910] [Cited by in Crossref: 41] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
17 Wang L, Sun Y, Zhao B, Zhang H, Yu Q, Yuan X. Chemotherapy plus targeted drugs in conversion therapy for potentially resectable colorectal liver metastases: a meta-analysis. Oncotarget 2016;7:55732-40. [PMID: 27248177 DOI: 10.18632/oncotarget.9675] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
18 Cassar N, Geoghegan J, Hoti E. Shifting concepts in the management of colorectal liver metastases. Surgeon 2022:S1479-666X(21)00200-6. [PMID: 34998701 DOI: 10.1016/j.surge.2021.12.005] [Reference Citation Analysis]
19 Hasselgren K, Sandström P, Björnsson B. Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: A review. World J Gastroenterol 2015; 21(15): 4491-4498 [PMID: 25914457 DOI: 10.3748/wjg.v21.i15.4491] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]